Oncternal Therapeutics Inc (ONCT)
Market Open
2 Dec, 21:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 53
-0.17
-24.121%
$
1.56M Market Cap
- P/E Ratio
- Div Yield
644,135 Volume
-10.66 Eps
$ 0.69
Previous Close Want to track ONCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.1 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ONCT Earnings Reports FAQ
What is the earnings per share (EPS) for ONCT?
The current EPS is -10.66.
What is the company's earnings growth rate?
Oncternal Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Oncternal Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Oncternal Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ONCT at this time, as Oncternal Therapeutics Inc has no recent EPS data to calculate it.
